Public annual accounts

DNA REPORTAGES financials

Name: DNA REPORTAGES financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DNA REPORTAGES, with comparable measures and links to available source documents.

Company overview

Registry number

0464349688

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for DNA REPORTAGES

2025 versus 2024

Operating line: €19,884
EBITDA: €15,152
Total assets: €187,293
Equity: €80,676

EBITDA margin +76.2% · Equity ratio +43.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Sept 2025	€19,884	€15,152	€187,293	€80,676	-
202430 Sept 2024	€31,849	€30,095	€184,882	€104,919	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report